9 unchanged sentences
Performance Graph
−Removed: The following performance graphs compare the cumulative total return on a $100 investment on December 31, 2015 and December 31, 2016, assuming reinvestment of all dividends, in:
−Removed: (i) our common shares, (ii) the S&P 500 Index, (iii) the S&P/TSX Composite Index and (iv) a composite peer group of 11 major U.S.
−Removed: based pharmaceutical companies for the four and five years ended December 31, 2020.
−Removed: The composite peer group of 11 major U.S.
−Removed: based pharmaceutical companies consists of Alexion Pharmaceuticals Inc, Amgen Inc, Biogen Inc, Bristol-Myers Squibb Co, Eli Lilly And Co, Endo International Plc, Jazz Pharmaceuticals Plc, Mallinckrodt Plc, Perrigo Company Plc, United Therapeutics Corp and Zoetis Inc.
+Added: The following performance graph compares the cumulative total return on a $100 investment on December 31, 2016, assuming reinvestment of all dividends, in:
+Added: (i) our common shares, (ii) the S&P 500 Index, (iii) the S&P/TSX Composite Index, (iv) a 2021 composite peer group of 10 major pharmaceutical companies and (v) a 2022 composite peer group of 14 major pharmaceutical companies for the five years ended December 31, 2021.
+Added: The 2021 composite peer group of 10 major pharmaceutical companies consists of Amgen Inc, Biogen Inc, Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International plc, Jazz Pharmaceuticals plc, Mallinckrodt plc, Perrigo Company plc, United Therapeutics Corporation and Zoetis Inc.
+Added: As a result of certain mergers involving our peer group, the Company completed an assessment to review its current peers and search for potential new peers.
+Added: This resulted in the 2022 composite peer group of 14 major pharmaceutical companies, which consists of Alcon Inc., Amgen Inc., Baxter International Inc., Biogen Inc, Cooper Companies Inc., Eli Lilly and Company, Endo International plc, Jazz Pharmaceuticals plc, Perrigo Company plc, Teva Pharmaceutical Industries Ltd., United Therapeutics Corporation, Viatris Inc., Zoetis Inc.
+Added: and Zimmer Biomet Holdings Inc.
Five Year Performance - Cumulative total return on a $100 investment on December 31, 2016
6 unchanged sentences
2021 Peer Group $100 $118 $133 $166 $185 $247
−Removed: Prior to 2016, the Company completed a series of mergers and acquisitions, which, at the time, were in-line with the Company's strategy for growth.
−Removed: However, in response to changing business dynamics within our Company, we recognized the need to change our focus in order to build a world-class health organization.
−Removed: To do so, in 2016, we retained a new executive team, which, in 2017, implemented a multi-year plan to stabilize, turnaround and transform our Company.
−Removed: The performance graph below of cumulative total return as of December 31, 2016 is provided to coincide with the implementation of the Company's turnaround strategies in 2017 to focus on our core businesses, eye-health, GI and dermatology.
−Removed: Four Year Performance - Cumulative total return on a $100 investment on December 31, 2016
−Removed: As of December 31,
−Removed: 2016 2017 2018 2019 2020
−Removed: Bausch Health Companies Inc.
−Removed: $100 $143 $127 $206 $143
−Removed: S&P 500 $100 $122 $116 $153 $181
−Removed: S&P/TSX Composite $100 $109 $99 $122 $129
2022 Peer Group $100 $114 $116 $144 $165 $200
4 unchanged sentences
Restrictions on Share Ownership by Non-Canadians
−Removed: There are no limitations under the laws of Canada or in our organizational documents on the right of foreigners to hold or vote securities of our Company, except that the Investment Canada Act (Canada) (the “Investment Canada Act”) may require review and approval by the Minister of Innovation, Science and Economic Development (Canada) (the “Minister”) of an acquisition of “control” of our Company by a “non-Canadian”.
+Added: There are no limitations under the laws of Canada or in our organizational documents on the right of foreigners to hold or vote securities of our Company, except that the Investment Canada Act (Canada) (the “Investment Canada Act”) may require review and approval by the Minister of Innovation, Science and Industry(Canada) (the “Minister”) of an acquisition of “control” of our Company by a “non-Canadian”.
Investment Canada Act
67 unchanged sentences
There were no purchases of equity securities by the Company during the fourth quarter of the year ended December 31, 2021.
−Removed: Selected Financial Data
−Removed: Not applicable.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.